NCT01621763View on ClinicalTrials.gov

Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Healthy
Interventions
DRUG

Clopidogrel

Clopidogrel Tablets 300 mg

Trial Locations (1)

Unknown

Lambda Therapeutic Research Ltd, Ahmedabad

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY

NCT01621763 - Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fed Conditions | Biotech Hunter | Biotech Hunter